9Suppliers
2Customers
3Debt Items
20Related Chains

Spruce Biosciences, Inc. Suppliers

TickerNameConfidenceEvidence
JEFFERIES-LLC JEFFERIES-LLC 92% Under the Sales Agreement, the Company may offer and sell, from time to time, through Jefferies as its sales agent and/or principal, shares (the “Shares”) of its common stock
LLY Eli Lilly and Company 92% Reciprocal relationship from LLY graph: Reciprocal relationship from SPRB graph: Pursuant to the terms of the Lilly License Agreement, Lilly granted us an exclusive, worldwide, royalty bearing, subli…
LLY Eli Lilly and Company 92% Pursuant to the terms of the Lilly License Agreement, Lilly granted us an exclusive, worldwide, royalty bearing, sublicensable license under certain technology, patent rights, know-how, and proprieta…
BMRN BioMarin Pharmaceutical Inc. 90% mmercial sale. In addition, we will also be entitled to receive a royalty for each unit of non-Company manufactured product sold equal to a range of double-digit percentages up to the mid-twenties ba…
BMRN BioMarin Pharmaceutical Inc. 90% Reciprocal relationship from BMRN graph: Reciprocal relationship from SPRB graph: mmercial sale. In addition, we will also be entitled to receive a royalty for each unit of non-Company manufactured p…
NBIX Neurocrine Biosciences, Inc. 72% Reciprocal relationship from NBIX graph: Reciprocal relationship from SPRB graph: her jurisdictions, all of which could seriously harm our business. 85 Table of Contents Item 1B. Unresolv ed Staff Co…
NBIX Neurocrine Biosciences, Inc. 72% her jurisdictions, all of which could seriously harm our business. 85 Table of Contents Item 1B. Unresolv ed Staff Comments. None. For example, cybersecurity risk is addressed as a component of the C…
TWST Twist Bioscience Corporation 72% and time-consuming, and the outcome is unpredictable. Even though we use commonly accepted security measures, the criteria for protection of trade secrets can vary among different jurisdictions. Enfo…
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: Reciprocal relationship from SPRB graph: and time-consuming, and the outcome is unpredictable. Even though we use commonly accepted security measures, the cri…

Spruce Biosciences, Inc. Customers

TickerNameConfidenceEvidence
TWST Twist Bioscience Corporation 72% nadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of these events occurs or if we otherwise lose protection for our trade secr…
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: Reciprocal relationship from SPRB graph: nadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. I…

Spruce Biosciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SPRB-DEBT Debt stack $6.8M 90% Market cache reports total debt of $6.8M.
SPRB-DEBT-12710 Warrants outstanding: 57000 90% xbrl warrant detail from xbrl 2025-12-31.
SPRB-DEBT-60637 Xbrl Convertible 90% xbrl convertible detail from xbrl 2026-01-07.

Spruce Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Spruce Biosciences, Inc..

Spruce Biosciences, Inc. Ownership

HolderNameConfidenceEvidence
SPRB-OWNER-IKARIAN-CAPITAL-LLC Ikarian Capital, LLC 90% 13F overlay lists Ikarian Capital, LLC as top holder; 32 tracked holders.

Spruce Biosciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DSGN Design Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2